SDZ PSC 833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein

Cancer Letters

Volumn 149, Issue 1-2, 2000, Pages 143-151

  Goulding, Celia W ^a   Giuliano, Armando E ^a   Cabot, Myles C ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Ceramide; Glucosylceramide; MCF 7 cells; P glycoprotein; SDZ PSC 833

Indexed keywords

CERAMIDE; CYCLOSPORIN A; GLUCOSYLCERAMIDE; GLYCOPROTEIN P; SPHINGOMYELIN;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CELL CLONE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG TRANSPORT; HUMAN; HUMAN CELL; LIPID ANALYSIS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ADENOCARCINOMA; BREAST NEOPLASMS; CERAMIDES; CYCLOSPORINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; P-GLYCOPROTEIN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0033963286     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00353-5     Document Type: Article

References (40)

1. Endicott J.A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58:1989;137-171.
2. Gottesman M.M., Pastan I. The multidrug transporter: a double-edged sword. J. Biol. Chem. 263:1988;12163-12166.
3. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:1993;385-427.
4. Chen C.J., Chin J.E., Ueda K., Clark D.P., Pastan I., Gottesman M.M., Roninson I.B. Internal duplication and homology with bacterial transport proteins in the mdrl (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 47:1986;381-390.
5. Gerlach J.H., Endicott J.A., Juranka P.F., Henderson G., Sarangi F., Deuchars K., Ling V. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature. 324:1986;485-489.
6. Bradley G., Ling V. P-glycoprotein, multidrug resistance and tumor progression. Cancer Metastasis Rev. 13:1994;223-233.
7. Slater L.M., Sweet P., Stupecky M., Gupta S. Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. J. Clin. Invest. 77:1986;1405-1408.
8. Twentyman P.R. Cyclosporins as drug resistance modifiers. Biochem. Pharmacol. 43:1992;109-117.
9. Covelli A. SDZ PSC 833: a novel modulator of MDR. Tumori. 83:1997;S21-S24.
10. Cabot M.C., Han T.-Y., Giuliano A.E. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation. FEBS Lett. 431:1998;185-188.
11. Hwang M., Ahn C., Pine P.S., Yin J., Hrycyna C., Licht T., Aszalos A. Effect of combination of suboptimal concentrations of P-glycoportein blockers on the proliferation of MDR1 gene expressing cells. Int. J. Cancer. 65:1996;389-397.
12. Archinal-Mattheis A., Rzepka R.W., Watanabe T., Kokubu N., Itoh Y., Combates N.J., Bair K.W., Cohen D. Analysis of the interactions of SDZ PSC 833 ([3′-keto-Bmtl-Val2]-cyclosporine), a multidrug resistance modulator, with P-glycoprotein. Oncol. Res. 7:1995;603-610.
13. Demeule M., Wenger R.M., Béliveau R. Molecular interactions of cyclosporin A with P-glycoprotein, photolabeling with cyclosporin derivatives. J. Biol. Chem. 272:1997;6647-6652.
14. Jarvis W., Grant S. The role of ceramide in the cellular response to cytotoxic agents. Curr. Opin. Oncol. 10:1998;552-559.
15. Liu Y.-Y., Han T.-Y., Giuliano A.E., Cabot M.C. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers Adriamycin resistance in human breast cancer cells. J. Biol. Chem. 274:1999;1140-1146.
16. Mathias S., Pena L.A., Kolesnick R.N. Signal transduction of stress via ceramide. Biochem. J. 335:1998;465-480.
17. Obeid L.M., Linaredic C.M., Karolak L.A., Hannun Y.A. Programmed cell death induced by ceramide. Science. 259:1993;1769-1771.
18. Lavie Y., Cao H.-T., Bursten S.L., Giuliano A.E., Cabot M.C. Accumulation of glucosylceramides in multidrug-resistant cancer cells. J. Biol. Chem. 271:1996;19530-19536.
19. Lucci A., Cho W.I., Han T.-Y., Giuliano A.E., Morton D.L., Cabot M.C. Glucosylceramide: a marker for multiple-drug resistant cancers. Anticancer Res. 18:1998;475-480.
20. Merrill A.H. Jr., Schmelz E.M., Dillehay D.L., Spiegel S., Shayman J.A., Schroeder J.J., Riley R.T., Voss K.A., Wang E. Sphingolipids the enigmatic lipid class: biochemistry, physiology and pathophysiology. Toxicol. Appl. Pharmacol. 142:1997;208-225.
21. Lavie Y., Cao H.-T., Volner A., Lucci A., Han T.-Y., Geffen V., Giuliano A.E., Cabot M.C. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J. Biol. Chem. 272:1997;1682-1687.
22. Cabot M.C., Giuliano A.E., Volner A., Han T.-Y. Tamoxifen retards glycosphingolipid metabolism in human cancer cells. FEBS Lett. 394:1996;129-131.
23. Sikic B.I., Fisher G.A., Lum B.L., Halsey J., Beketic-Oreskovic L., Chen G. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother. Pharmacol. 40:1997;S13-S19.
24. Cabot M.C., Giuliano A.E., Han T.-Y., Lui Y.-Y. SDZ PSC 833, the cyclosporine A analog and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug resistant cancer cells. Cancer Res. 59:1999;880-885.
25. Clarke R., Currier S., Kaplan O., Lovelace E., Boulay V., Gottesman M.M., Dickson R.B. Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells. J. Natl. Cancer Inst. 84:1992;1506-1512.
26. Bennis S., Faure P., Chapey C., Hu Y., Fourche J., El Yamani J., Robert J. Cellular pharmacology of lipophilic anthracyclines in human tumor cells in culture selected for resistance to doxorubicin. Anticancer Drugs. 8:1997;610-617.
27. Clarke R., Dickson R.B., Lippman M.E. Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions. Crit. Rev. Oncol. Hematol. 12:1991;1-23.
28. Clarke R., Lippman M.E., Dickson R.B. Mechanism of hormone and cytotoxic drug interactions in the development and treatment of breast cancer. Prog. Clin. Biol. Res. 322:1990;243-278.
29. Molina R., Oesterrich S., Zhou J.L., Tandon A.K., Clark G.M., Allred D.C., Townsend A.J., Moscow J.A., Cowan K.H., McGuire W.L. Glutathione transferase GST pi in breast tumors evaluated by three techniques. Dis. Markers. 11:1993;71-82.
30. Morrow C., Chiu J., Cowan K. Posttranscription control of glutathione-S-transferase pi gene expression in human breast cancer cells. J. Biol. Chem. 267:1992;10544-10550.
31. Zyad A., Benard J., Tursz T., Clarke R., Chouaib S. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1. MnSOD, and TNF gene expression. Cancer Res. 54:1994;825-831.
32. Tuccari G., Rizzo A., Giuffre G., Barresi G. Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: correlation with clinico-pathogical features. Virchows Arch. A. Pathol. Anat. Histopathol. 423:1993;51-55.
33. Schneider E., Horton J., Yang C., Nakagawa M., Cowan K. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF-7 cell line selected for etoposide resistance. Cancer Res. 54:1994;152-158.
34. Bose R., Verheij M., Halmovitx-Friedman A., Scotto K., Fuks Z., Kolesnick R. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell. 82:1995;405-414.
35. Jaffrezou J.-P., Levade T., Bettaieb A., Andrieu N., Bezombes C., Maestre N., Vermeersch S., Rousse A., Laurent G. Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J. 15:1996;2417-2424.
36. Michael J., Lavin M.F., Watters D.J. Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. Cancer Res. 57:1997;3600-3605.
37. Santana P., Pena L.A., Haimovitz-Friedman A., Martin S., Green D., McLoughlin M., Cordon-Cardo C., Schuchinan E.H., Fuks Z., Kolesnick R. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell. 86:1996;189-199.
38. Lucci A., Giuliano A.E., Han T.-Y., Dinur T., Liu Y.-Y., Senchenkov A., Cabot M.C. Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells. Int. J. Oncol. 15:1999;535-540.
39. Merlin J., Guerci A., Marchal S., Bour C., Colosetti P., Kataki A., Guerci O. SDZ PSC 833 modulation of daunorubicin intracellular accumulation in bone marrow specimens from patients with acute myeloid leukemias. Br. J. Haematol. 103:1998;480-487.
40. Haimovitz-Friedman A., Kolesnick R., Fuks Z. Ceramide signaling in apoptosis. Br. Med. Bull. 53:1997;539-553.